■在各种牙齿置换治疗方式中,牙科植入物被认为是最好的。这项研究评估了吸烟的影响,牙周炎,和糖尿病对接受皮质基牙种植的患者口腔健康相关生活质量(OHRQoL)的影响。
■共纳入120名接受皮质基牙种植体的患者。所有患者均接受了牙种植体患者的口腔健康影响概况-20(OHIP-20)(OHRQoL问卷)。患者满意度水平是在0到5分范围内的量表上测量的。值0表示不满意,而值5显示高度满意。
■120名患者中,男性为70,女性为50。总体满意度为4.92,衔接语音为4.12,植入物为4.80,施工为4.88。总体满意度,衔接演讲,植入物,有和无糖尿病患者的构建值分别为4.90vs4.93、4.56vs4.86、4.76vs4.92和4.94vs4.83。总体满意度,衔接演讲,植入物,有吸烟和无吸烟患者的构造值分别为4.83vs4.91,4.52vs4.88,4.70vs4.82和4.12vs4.84。总体满意度,衔接演讲,植入物,有和无牙周炎患者的构建值分别为4.72vs4.96、4.52vs4.88、4.73vs4.98和4.81vs4.95。总体满意度,衔接演讲,植入物,具有一到三个危险因素和对照的患者的构造值分别为4.85vs4.96,4.82vs4.94,4.88vs4.97和4.76vs4.86。疼痛有显著差异,感染和/或肿胀,睡眠问题,自信的问题,味道,咀嚼不适和/或困难,皮质基牙种植体治疗前后对食物选择的影响(P<0.05)。
■糖尿病患者获得皮质基牙种植体后满意度较高,吸烟,与对照组相比,牙周炎。因此,皮质基牙种植体可被视为这些患者的替代治疗方案.
UNASSIGNED: Among various treatment modalities for tooth replacement, dental implants are considered the best one. This study assessed the effects of smoking, periodontitis, and diabetes on oral health-related quality of life (OHRQoL) in patients receiving corticobasal dental implants.
UNASSIGNED: One hundred twenty patients of either gender who received corticobasal dental implants were enrolled. All were subjected to Oral Health Impact Profile-20 (OHIP-20) for dental implant patients (OHRQoL questionnaire). The patient satisfaction level was measured on a scale with points ranging from 0 to 5. The value 0 indicates no satisfaction, whereas the value 5 shows highly satisfied.
UNASSIGNED: Of 120 patients, males were 70 and females were 50. The overall satisfaction level was 4.92, articulation speech was 4.12, implants were 4.80, and construction was 4.88. The overall satisfaction, articulation speech, implants, and construction values in patients with and without diabetes were 4.90 vs 4.93, 4.56 vs 4.86, 4.76 vs 4.92, and 4.94 vs 4.83, respectively. The overall satisfaction, articulation speech, implants, and construction values in patients with and without smoking were 4.83 vs 4.91, 4.52 vs 4.88, 4.70 vs 4.82, and 4.12 vs 4.84, respectively. The overall satisfaction, articulation speech, implants, and construction values in patients with and without periodontitis were 4.72 vs 4.96, 4.52 vs 4.88, 4.73 vs 4.98, and 4.81 vs 4.95, respectively. The overall satisfaction, articulation speech, implants, and construction values in patients with one to three risk factors and control were 4.85 vs 4.96, 4.82 vs 4.94, 4.88 vs 4.97, and 4.76 vs 4.86, respectively. There was a significant difference in pain, infections and/or swelling, sleeping problems, problems with self-confidence, taste, chewing discomfort and/or difficulties, and influence on food choice before and after in patients treated with corticobasal dental implants (P < 0.05).
UNASSIGNED: The satisfaction level is higher after obtaining corticobasal dental implants in patients with diabetes, smoking, and periodontitis as compared to control. Thus, corticobasal dental implants may be considered alternate treatment options for these patients.